Multi-Antigen Viral-Vectored Vaccine Protects Against SARS-CoV-2 and Variants in a Lethal hACE2 Transgenic Mouse Model - Stone, Shannon; Elsharkawy, Amany; Burleson, J. D.; Hauser, Mary; Domi, Arban; Kumari, Pratima; Nabi, Zainab; Natekar, Janhavi P.; Porto, Maciel; Backstedt, Brian; Newman, Mark; Oruganti, Sreenivasa Rao; et al. (Vaccines (Basel), 2025)
Keywords: Animals; Antibodies; Antigens; COVID-19; COVID-19 vaccines; Effectiveness; Enzymes; Genes; Immune response; Immunogenicity; Infections; Lungs; Lymphocytes; Lymphocytes T; Microscopy; MVA-VLP; Olfactory bulb; Peptides; Proteins; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Transgenic mice; Vaccine efficacy; Vaccines; Viral diseases; Viruses; United States; COVID-19; SARS-CoV-2; MVA-VLP